Back
Achilles Therapeutics PLC Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
ACHL
Achilles Therapeutics PLC
Last Price:
1.06
Seasonality Move:
-11.82%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Achilles Therapeutics PLC Stock Forecast
-
Is Achilles Therapeutics PLC Stock Undervalued?
The current Achilles Therapeutics PLC [ACHL] share price is $1.06. The Score for ACHL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal. - ACHL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Achilles Therapeutics PLC Stock Go Up Next Year?
Data Unavailable
Achilles Therapeutics PLC Stock Rating
Data Unavailable
Achilles Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
achillestx.com
52-Week Data
52-Week High:
1.76
52-Week Low:
0.63
Prediction Charts
Market Cap:
43.55M
Price in USD:
1.06
Volume:
410.91K
Beta:
1.36
Technical Analysis
SMA50:
0.99
SMA100:
0.88
SMA200:
0.94
52-Wk Change:
32.83%
Stock Predictions
-
Is Achilles Therapeutics PLC stock public?
Yes, Achilles Therapeutics PLC is a publicly traded company. -
What is the Achilles Therapeutics PLC stock quote today?
The Achilles Therapeutics PLC stock price is 1.06 USD today. -
How to buy Achilles Therapeutics PLC stock online?
You can buy Achilles Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-5 | 1.01 | 1.04 | 1.05 | 1.00 |
| Nov-6 | 1.04 | 1.05 | 1.06 | 1.01 |
| Nov-7 | 1.05 | 1.05 | 1.07 | 1.03 |
| Nov-8 | 1.03 | 1.05 | 1.05 | 1.03 |
| Nov-11 | 1.04 | 1.04 | 1.05 | 1.01 |
| Nov-12 | 1.02 | 1.01 | 1.02 | 1.00 |
| Nov-13 | 1.01 | 1.02 | 1.02 | 0.99 |
| Nov-14 | 1.05 | 1.07 | 1.12 | 1.05 |
| Nov-15 | 1.05 | 1.05 | 1.08 | 1.02 |
| Nov-18 | 1.04 | 1.05 | 1.06 | 1.03 |
| Nov-19 | 1.03 | 1.05 | 1.05 | 1.01 |
| Nov-20 | 1.04 | 1.07 | 1.07 | 1.02 |
| Nov-21 | 1.05 | 1.07 | 1.08 | 1.05 |
| Nov-22 | 1.05 | 1.06 | 1.08 | 1.01 |
Achilles Therapeutics PLC Earnings
Data Unavailable
Achilles Therapeutics PLC Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and an increase next year of $0.70 per share.
* Achilles Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.